SPL 3.00% 9.7¢ starpharma holdings limited

Another ADC Buyout - Just not SPL, page-23

  1. 3,325 Posts.
    lightbulb Created with Sketch. 780
    I’d say that Gilead lost Starpharma’s phone number a long time ago. They just stumped up US$4.3B to expand their portfolio. (Not in ADCs)

    Was it just a message that Starpharma left on an answering machine? “Oh hey it’s Starpharma here, we’ve developed DEP-Remdesivir. Please call us back to discuss.”

    Still waiting…

    https://investors.gilead.com/news/news-details/2024/Gilead-Sciences-Expands-Liver-Portfolio-With-Acquisition-of-CymaBay-Therapeutics/default.aspx
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.7¢
Change
-0.003(3.00%)
Mkt cap ! $40.00M
Open High Low Value Volume
10.0¢ 10.0¢ 9.6¢ $44.81K 460.0K

Buyers (Bids)

No. Vol. Price($)
1 9800 9.7¢
 

Sellers (Offers)

Price($) Vol. No.
9.9¢ 239 1
View Market Depth
Last trade - 15.58pm 17/07/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.